Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2012.0243
NEWS & VIEWS
|
Tyrosine kinase inhibitors expand indications for surgical resection of advanced GIST. |
Prof. Theodore Liakakos, MD, PhD
|
Affiliation: Theodore Liakakos, MD, Professor of Surgery, 3rd Department of Surgery, University of Athens, School of Medicine, Attikon University Hospital, Rimini 1, Chaidari, Athens 12462, Greece.
E-mail: theodlia@otenet.gr |
Since there is no abstract available we provide the first paragraph
Imatinib, a small-molecule selective tyrosine-kinase inhibitor, is associated with high responsiveness in patients with gastrointestinal stromal tumors and it has been the standard adjuvant systemic treatment after tumor resection. This efficacy raises the question of laparoscopic surgery also in the treatment of locally advanced or metastatic GIST.
(Citation: Gastric & Breast Cancer 2011; 11(4):
233-235)
|
|
| You can have an online full-text access and a PDF of this article: |
- Either purchase this paper for €35 EUR. Please, click here
|
|
- Or through one year subscription PayPal
|
|
Online
ISSN : 1109 - 7647
Print ISSN : 1109 - 7655
 We
subscribe to the HONcode principles. Verify
here.
please, read our policy about privacy
and confidentiality of information and transparency
of sponsorship
last
update: 31 October 2012 |
|
